Nitrofurantoin PCD Pharma Franchise Company
Cafoli Lifecare is a dependable Nitrofurantoin PCD pharma franchise company in India, offering 5 Nitrofurantoin formulations across tablets and suspension. Each batch is manufactured at WHO-GMP certified, DCGI-approved facilities, and franchise partners receive exclusive district-wise monopoly rights on the full urology and anti-infective range.
What is Nitrofurantoin?
Nitrofurantoin is a synthetic nitrofuran antibacterial used specifically for urinary tract infections. It is concentrated in the urine, where bacterial enzymes reduce it to reactive intermediates that damage bacterial ribosomal proteins, DNA and metabolic enzymes — a multi-target mechanism that explains why bacterial resistance to it has remained low. It is indicated for uncomplicated lower urinary tract infection and for UTI prophylaxis, and is listed on the WHO Model List of Essential Medicines.
Available Nitrofurantoin Formulations
The Cafoli Lifecare Nitrofurantoin range comprises 5 formulations in the following dosage forms:
Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the current Nitrofurantoin price list.
Therapeutic Applications of Nitrofurantoin
Prescribed under medical supervision for:
- Acute uncomplicated lower urinary tract infection (cystitis)
- Long-term prophylaxis of recurrent urinary tract infection
- UTI in pregnancy, where appropriate and under obstetric supervision
- Paediatric urinary tract infection, as suspension
Prescriber specialties: urologists, consulting physicians, gynaecologists, nephrologists and paediatricians. Nitrofurantoin is a prescription-only antibiotic and should be used in line with antimicrobial stewardship guidance.
Why Nitrofurantoin is a High-Potential Molecule for Distributors
Nitrofurantoin occupies a rare position in the anti-infective market: it is an old antibiotic whose clinical value is rising rather than falling. As fluoroquinolone and co-trimoxazole resistance has climbed across India, treatment guidelines have pushed Nitrofurantoin back to first-line status for uncomplicated cystitis, and antimicrobial stewardship programmes actively favour it because it is narrow-spectrum and urine-specific. For a franchise partner this means a molecule with guideline tailwinds instead of headwinds. Recurrent UTI is also common in women and in diabetics, and prophylactic courses run for months — so alongside the fast-moving acute business there is a genuine repeat-prescription tail. The availability of a paediatric suspension widens the prescriber base beyond urology into general and child practice.
Why Choose Cafoli Lifecare
- Monopoly rights — exclusive district-wise marketing rights for the Nitrofurantoin range
- WHO-GMP certified manufacturing and DCGI-approved products
- Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
- 1000+ franchise partners across India with an on-time dispatch record
- Transparent net rates and dedicated franchise support
References
- WHO Model List of Essential Medicines
- PubChem — Nitrofurantoin compound record
- PubMed — Nitrofurantoin in uncomplicated UTI
Our formulations of Nitrofurantoin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: